title: [Recytoreductive surgery for recurrent epithelial ovarian cancer].
abstract: OBJECTIVE
  To evaluate the role of recytoreductive surgery (RCRS) in recurrent epithelial ovarian cancer.
  
  
  METHODS
  Fifty-five patients who underwent recytoreductive surgery at Peking Union Medical College Hospital between Nov. 1998 and Apr. 2002 were retrospectively reviewed. They were divided into four groups firstly by the identity of recurrent lesion: group A, single lesion; B, disseminated lesion; C, intestinal obstruction; D, palliative surgery. Then they were divided into 3 groups according to the sensitivity to chemotherapy. Group A, diseases relapsed more than 6 months after chemotherapy; group B, relapsed less than 6 months; group C, relapsed during chemotherapy. We review the cases with regard to its macroscopic residual disease, complications of operation, cases with complete remission and partial remission, postoperation survival time and disease-free interval.
  
  
  RESULTS
  Recytoreductive surgery for patients with isolated recurrent tumor were optimal. For those diagnosed as local lesion preoperatively, 61% of these cases were found to have disseminated diseases postioeratively. Sixty-five percents of these cases received optimal RCRS, but their prognosis were not as well as those with real isolated leasion (response rate: 36% vs 67%). Cases with different sensitivity to chemotherapy had different prognosis (response rate: A, 50%; B, 26%; C, 28%).
  
  
  CONCLUSIONS
  Recytoreductive surgery should be considered in patients with isolated recurrent ovarian cancer and patient with recurrence more than 6 months after chemotherapy.
authors.affiliation: Department of Obsterics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100730, China.
authors.forename: Chen-wei
authors.initials: CW
authors.lastname: Fu
authors.forename: Keng
authors.initials: K
authors.lastname: Shen
authors.forename: Ming
authors.initials: M
authors.lastname: Wu
authors.forename: Hui-fang
authors.initials: HF
authors.lastname: Huang
authors.forename: Ling-ya
authors.initials: LY
authors.lastname: Pan
authors.forename: Jing-he
authors.initials: JH
authors.lastname: Lang
mesh_terms: D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000601:surgery*; D009375:Neoplasms, Glandular and Epithelial / Q000401:mortality / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000401:mortality / Q000601:surgery*; D011183:Postoperative Complications / Q000209:etiology; D012086:Reoperation